HONG KONG – In the aftermath of last year's highly controversial case of a researcher announcing the birth of two gene-edited babies in China, the National Health Commission (NHC) released a set of draft regulations that increases scrutiny over the use of new high-risk biomedical technologies, such as gene editing, stem cell technology, cloning and assisted reproduction.